The correlation between obesity and risk of prostate cancer (CaP) to include the progression of CaP has been an area of significant investigation. Greater height has also been proposed to be a risk factor for CaP, due to increased levels of bioavailable insulin-like growth factors (IGFs) or androgens, or genetic predisposition. This relationship is supported in some but not all studies. In the online edition of the British Journal of Cancer, Dr. Ahn and colleagues used the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial to explore this association.
Read more at Medical News Today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment